{"public_id":"co_e821998bf2818625a320c7ac159bce1e","status":"active","merged_into_public_id":null,"resolved_public_id":"co_e821998bf2818625a320c7ac159bce1e","name":"corpora lutea","description":"Ovarian structures that produce progesterone during the luteal phase and pregnancy.","aliases":["CL"],"types":["anatomical structure"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":17326149,"title":"GnRH agonist treatment decreases progesterone synthesis, luteal peripheral benzodiazepine receptor mRNA, ligand binding and steroidogenic acute regulatory protein expression during pregnancy.","citation_count":55,"url":"https://sah.borca.ai/papers/17326149"}],"claims":[{"public_id":"cl_d6e6208731dcc081426f487d8a397509","text":"GnRH agonist treatment also reduces P450 scc protein and activity in the corpora lutea, and these levels remain low relative to sham controls.","corpus_id":17326149,"url":"https://sah.borca.ai/claims/cl_d6e6208731dcc081426f487d8a397509"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_e821998bf2818625a320c7ac159bce1e","url":"https://sah.borca.ai/concepts/co_e821998bf2818625a320c7ac159bce1e"}